[1]齐士魁,高静,余明月,等.脑卒中后抑郁发病机制的研究进展[J].卒中与神经疾病杂志,2022,29(05):483-486.[doi:10.3969/j.issn.1007-0478.2022.05.019]
点击复制

脑卒中后抑郁发病机制的研究进展()
分享到:

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第29卷
期数:
2022年05期
页码:
483-486
栏目:
综述
出版日期:
2022-10-10

文章信息/Info

文章编号:
1007-0478(2022)05-0483-04
作者:
齐士魁高静余明月聂晨晨冯晓东
450000 郑州,河南中医药大学康复医学院(齐士魁 余明月 聂晨晨); 河南中医药大学第一附属医院康复中心[高静 冯晓东(通信作者)]
分类号:
R743.3
DOI:
10.3969/j.issn.1007-0478.2022.05.019
文献标志码:
A

参考文献/References:

[1] Mitchell AJ, Sheth B, Gill J, et al. Prevalence and predictors of post-stroke mood disorders: A meta-analysis and meta-regression of depression, anxiety and adjustment disorder[J]. Gen Hosp Psychiatry, 2017, 47(2): 48-60.
[2] 王少石,周新雨,朱春燕.卒中后抑郁临床实践的中国专家共识[J].中国卒中杂志,2016,11(8):685-693.
[3] Richter D, Charles JJ, Ebert A, et al. Selective serotonin reuptake inhibitors for the prevention of Post-Stroke depression: a systematic review and Meta-Analysis[J]. J Clin Med, 2021, 10(24): 5912.
[4] 赵涵,程一升,张辉.醒脑解郁汤治疗卒中后抑郁的疗效及对血清NE、5-HT水平影响[J].中华中医药学刊,2021,39(11):1-10.
[5] 蒋岚,田慧军,黄伟.针灸联合黛力新治疗脑卒中后抑郁疗效及对患者血清神经递质水平的影响[J].陕西中医,2019,40(8):1134-1137.
[6] 孙晓东,杨宁,车文生.针刺治疗脑卒中后抑郁患者的疗效及对神经营养状态、单胺类神经递质的影响[J].世界中医药,2018,13(9):2285-2287+2291.
[7] 王振垚.针刺颈夹脊穴对卒中后血管性痴呆患者血清BDNF,VEGF,MMP-9水平的影响[J].上海针灸杂志,2019,38(08):842-847.
[8] 何文绮,顾寒英.左洛复联合尼麦角林对缺血性脑卒中后抑郁患者血清神经因子及炎症因子的影响[J].心脑血管病防治,2020,20(1):107-109.
[9] Shan D, Zheng Y, Froud K. Brain-Derived neurotrophic factor as a clinical biomarker in predicting the development of Post-Stroke depression: a review of evidence[J]. Cureus, 2021, 13(6): e15662.
[10] Xu HB, Xu YH, He Y, et al. Decreased serum Brain-Derived neurotrophic factor May indicate the development of poststroke depression in patients with acute ischemic stroke: a Meta-Analysis[J]. J Stroke Cerebrovasc Dis, 2018, 27(3): 709-715.
[11] 林荫,罗海东,刘向来,等.卒中后抑郁患者血清BDNF水平变化的临床意义[J].疑难病杂志,2019,18(1):39-43.
[12] Kang Z, Ye H, Chen T, et al. Effect of electroacupuncture at siguan acupoints on expression of BDNF and TrkB proteins in the hippocampus of Post-Stroke depression rats[J]. J Mol Neurosci, 2021, 71(10): 2165-2171.
[13] Villa RF, Ferrari F, Moretti A. Post-stroke depression: Mechanisms and pharmacological treatment[J]. Pharmacol Ther, 2018, 184(4): 131-144.
[14] Lichlyter DA, Krumm ZA, Golde T, et al. Role of CRF and the hypothalamic-pituitary-adrenal axis in stroke: revisiting temporal considerations and targeting a new Generation of therapeutics[J]. FEBS J, 2022(3): 107-121.
[15] Gold PW. Endocrine factors in key structural and intracellular changes in depression[J]. Trends Endocrinol Metab, 2021, 32(4): 212-223.
[16] Yang M, Luo Y, Hao XZ, et al. Effects of high temperature and high humidity stress on the negative feedback regulation of hippocampus on HPA axis in rats[J]. Neuro Endocrinol Lett, 2021, 42(5): 312-320.
[17] 赵欣,姬孟艳,董强.厚朴酚对脑卒中后抑郁小鼠神经炎症及HPA轴的影响[J].神经损伤与功能重建,2020,15(11):645-647.
[18] 刘晓敏,张雅素,李新民,等.有氧运动改善脑卒中后抑郁与肠道菌群相关性的研究进展[J].中国康复医学杂志,2021,36(8):1040-1045.
[19] Wei W, Karim HT, Lin C, et al. Trajectories in cerebral blood flow following antidepressant treatment in Late-Life depression: support for the vascular depression hypothesis[J]. J Clin Psychiatry, 2018, 79(6): 18m12106.
[20] 杨红华,谭嘉惠,沈冬敏.老年人高血压脑卒中后抑郁情况及危险因素分析[J].深圳中西医结合杂志,2020,30(18):22-24.
[21] Cheng LS, Tu WJ, Shen Y, et al. Combination of High-Sensitivity C-Reactive protein and homocysteine predicts the Post-Stroke depression in patients with ischemic stroke[J]. Mol Neurobiol, 2018, 55(4): 2952-2958.
[22] 赵然然,罗小兰.同型半胱氨酸水平同缺血性卒中患者脑小血管病总体负担的相关性研究[J].华西医学,2019,34(4):394-399.
[23] 麦惠婷,叶建军,李铺,等.急性缺血性脑卒中后抑郁与脑小血管病患者负荷轻重程度的相关性分析[J].中国处方药,2021,19(5):174-175.
[24] 陈晨,王晓静,曹珊珊,等.脑小血管病患者共情与认知功能的相关性[J].中华行为医学与脑科学杂志,2020(3):227-228.
[25] Zhang W, Tian T, Gong SX, et al. Microglia-associated neuroinflammation is a potential therapeutic target for ischemic stroke[J]. Neural Regen Res, 2021, 16(1): 6-11.
[26] Heinz R, Brandenburg S, Nieminen-Kelhä M, et al. Microglia as target for anti-inflammatory approaches to prevent secondary brain injury after subarachnoid hemorrhage(SAH)[J]. J Neuroinflammation, 2021, 18(1): 36.
[27] 胡佳,周伟,周志明,等.炎症指标对缺血性脑卒中卒中后抑郁的预测价值[J].南方医科大学学报,2019,39(6):665-671.
[28] Hu J, Wang L, Fan K, et al. The association between systemic inflammatory markers and Post-Stroke depression: a prospective stroke cohort[J]. Clin Interv Aging, 2021, 16(7): 1231-1239.
[29] 连春雨,刘宏岩,张兆鹏,等.柴桂解郁开心方对脑卒中后抑郁大鼠血清炎症因子及海马自噬相关蛋白的影响[J].中国老年学杂志,2021,41(9):1900-1903.
[30] Yi X, Zhu X, Zhou Y, et al. The combination of insulin resistance and serum interleukin-1β correlates with Post-Stroke depression in patients with acute ischemic stroke[J]. Neuropsychiatr Dis Treat, 2021, 17(7): 735-746.
[31] Moreno-Jiménez EP, Terreros-Roncal J, Flor-García M, et al. Evidences for adult hippocampal neurogenesis in humans[J]. J Neurosci, 2021, 41(12): 2541-2553.
[32] Wang J, Ware K, Bedolla A, et al. Disruption of sonic hedgehog signaling accelerates Age-Related neurogenesis decline and abolishes Stroke-Induced neurogenesis and leads to increased anxiety behavior in stroke mice[J]. Transl Stroke Res, 2022, 37(9): 337-351.
[33] Troubat R, Barone P, Leman S, et al. Neuroinflammation and depression: A review[J]. Eur J Neurosci, 2021, 53(1): 151-171.
[34] Apple DM, Fonseca RS, Kokovay E. The role of adult neurogenesis in psychiatric and cognitive disorders[J]. Brain Res, 2017, 1655(13): 270-276.
[35] Huiling T, Xiaoli L, Qisheng T, et al. Yi-nao-jie-yu prescription exerts a positive effect on. neurogenesis by regulating notch signals in the hippocampus of post-stroke depression rats[J]. Frontiers in Psychiatry, 2018, 9(1): 483-497.
[36] Jiang H, Xiao L, Jin K, et al. Estrogen administration attenuates post-stroke depression by enhancing CREB/BDNF/TrkB signaling in the rat hippocampus[J]. Exp Ther Med, 2021, 21(5): 433.
[37] 邱璇.有氧运动调控雌激素对阿尔茨海默病的神经保护作用[J].中国老年学杂志,2021,41(8):1784-1788.
[38] 蒋慧刚,肖丽,张红霞,等.雌激素对脑卒中后抑郁大鼠海马和杏仁核脑源性生长因子-磷酸化酪氨酸激酶B表达以及行为学的影响[J].中国临床神经科学,2014,22(02):146-153.
[39] Nalvarte I, Varshney M, Inzunza J, et al. Estrogen receptor beta and neural development[J]. Vitam Horm, 2021, 116(5): 313-326.
[40] 肖丽,邵蓓,蒋慧刚,等.雌激素对脑卒中后抑郁大鼠行为学和神经再生的剂量相关性研究[J].中国临床神经科学,2014,22(2):154-159.
[41] Parkin GM, Udawela M, Gibbons A, et al. Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders[J]. World J Psychiatry, 2018, 8(2): 51-63.
[42] 严嘉宁,赵立峰,余涛,等.电针对脑卒中后抑郁大鼠谷氨酸类神经递质及其受体的表达影响[J].宁波大学学报(理工版),2018,31(3):72-75.
[43] Zhao A, Ma B, Xu L, et al. Jiedu tongluo granules ameliorates post-stroke depression rat model via regulating NMDAR/BDNF signaling pathway[J]. Front Pharmacol, 2021, 12(9): 662003.
[44] Pajarillo E, Rizor A, Lee J, et al. The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics[J]. Neuropharmacology, 2019, 161(3): 107559.
[45] Liu J, Guo ZN, Yan XL, et al. Crosstalk between autophagy and ferroptosis and its putative role in ischemic stroke[J]. Front Cell Neurosci, 2020, 14(6): 577403.
[46] Frank D, Kuts R, Tsenter P, et al. The effect of pyruvate on the development and progression of post-stroke depression: A new therapeutic approach[J]. Neuropharmacology, 2019, 155(5): 173-184.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金青年项目(82104973)
更新日期/Last Update: 2022-10-10